Coronavirus

The unexpected outbreak of coronavirus has caused fear of uncertainty for future and I am sure the outcome will shape many respects of the world No.2 economy. However, the nature of being smart, hardworking, and kindness Chinese just as described as personality of being rate in Chinese lunar book. Therefore, we should continue.. In January, TMFOX released report on POC (Point of Care) of China and I welcome global innovators and investors to work with TMFOX for value investing and better wellness to people. I also congratute our  client Sonic Incytes Medical based in Vancouver finalized its later seed fundraising and the success of this round definitely fuel the company to FDA process and early market access in both U.S and China.

Coronavirus Impacts

The outbreak of coronavirus in China is not a casual crisis,but a outcome of problems unsolved in past 40 years. It is a time to re-think root causes and solutions for future:

  • I can not predict how much worse the conronavirus damage the GDP of China at moment, but in general, the worsest the economy could be, the greatest potential it could re-bounced;
  • Policies makers in China will re-examine governmental spending and regulatory, especially health care system, public safety, and national R&D ecosystem. Some polit projects such as integrated healthcare system, electronic medical records, primary care will complete validation and execute at nation level.
  • Many small and medium business in high tech will be out of market in next 3 months, especially those are in low profit margin (less than 6%) and low rate of capital turnover .
  • Entrepreneurs are likely to suspend their long term stratety and concentrate suvivial plan at moment, this means they refocus on cash cow product, eliminate management process and headcount.
  • 80-90s Employee will encounter the most fierce competition in job market due to foreseen umployment rate, they have to rebuid their knowledge, skills, and re-define imployment relationship.
  • People will re-examine their relationship to nature, social value, government, community in terms of social responsibilities.

Research Highlights: China POCT Investing in 2020-2030

  • In the future, market forces such as retail, insurance, internet, community service and other organizations will bring consumers together to participate in the innovation of the primary medical system. These forces will drive traditional medical institutions and regulators to make concessions and get involved in innovation.
  • In the next 10 years, the global economic will be in turmoil, relative to the short lifespan of new technologies and the weakness of fixed income investments, investments based on POC and POCT will provide safe returns and lead a growth trend (CAGR greater than 10%).
  • POCT’s technological innovations (artificial intelligence, automation, biosensors, biochips) can completely replace some of the human labor in the medical system. We have every reason to believe that machine learns faster than human does, and that machines are not affected by emotions and physical limit.

POC should be on the front line of healthcare and bear at least 80% of the outpatient volume. As long as the quality is guaranteed, the service is convenient, and the price is affordable, there will be no doubt that patients are willing to accept the proximate primary medical service.

The complete report is downloadable from https://www.tmfox.com/the-value-of-poct-point-of-care-technology-investing-in-2020-2/  (English Version), and http://club-vc.com.cn/index/2020-02-06/28.html (Chinese 中文).

Sonic Incytes Medical completed last seed fundraising

Prof. Robert Rohling and Prof. Tim Salcudean started Sonic Incytes Medical at their lab at the University of British Columbia and later was incubated by Hatch Accelator at UBC. Sonic Incytes Medical focus on 400 million liver disease in U.S and China market and empowers POC (point of care) via accurate, portable, and costs saving diagnosis and paitent care technologies. With completion of this round leading by industry partner and venture capital globally, the client is in fast pace of FDA,early market validation, team building.

Write a Comment